ABSI vs NCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ABSI

38.4
AI Score
VS
NCI Wins

NCI

45.3
AI Score

Investment Advisor Scores

ABSI

38score
Recommendation
EXTENDED

NCI

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABSI NCI Winner
Forward P/E 0 0 Tie
PEG Ratio 0 1.13 Tie
Revenue Growth -46.4% -50.8% ABSI
Earnings Growth 0.0% 34.0% NCI
Tradestie Score 38.4/100 45.3/100 NCI
Profit Margin 0.0% 0.2% NCI
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

ABSI 1M: +25.8% · 3M: -4.1% NCI 1M: -93.6% · 3M: -92.7%

Current Technical Phase

ABSI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 63.8 · Price: $11.07

NCI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.2%), weak momentum, RSI 14

RSI (14): 14.3 · Price: $0.86

Fundamentals Snapshot

Metric ABSI NCI
Market Cap — —
Forward P/E -16.4 0.0
Trailing P/E — 13.3
Revenue (TTM) — —
Revenue Growth -0.5% -0.5%
Gross Margin -54.0% 0.4%
Operating Margin -107.4% 0.0%
EPS -0.79 0.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.